Arbutin protects HK-2 cells against high glucose-induced apoptosis and autophagy by up-regulating microRNA-27a

References

• Ma ZJ, Sun P, Guo G, et al. Association of the HLA-DQA1 and HLA-DQB1 alleles in type 2 diabetes mellitus and diabetic nephropathy in the han ethnicity of China. J Diabetes Res. 2013;2013:1–452537.
   Web of Science ®Google Scholar
• Senthilkumar GP, Anithalekshmi MS, Yasir M, et al. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy. Diabetes Metab Syndr. 2018;12:23–26.
   PubMed Web of Science ®Google Scholar
• Lv M, Chen Z, Hu G, et al. Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives. Drug Discov Today. 2015;20:332–346.
   PubMed Web of Science ®Google Scholar
• Duran-Salgado MB, Rubio GA. Diabetic nephropathy and inflammation. WJD. 2014;5:393–398.
   Google Scholar
• Afkarian M, Zelnick LR, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988–2014. JAMA. 2016;316:602–610.
   PubMed Web of Science ®Google Scholar
• Lim AK. Diabetic nephropathy - complications and treatment. Int J Nephrol Renovascul Dis. 2014;7:361–381.
   PubMedGoogle Scholar
• Zhu Y, Cui H, Xia Y, et al. RIPK3-mediated necroptosis and apoptosis contributes to renal tubular cell progressive loss and chronic kidney disease progression in rats. PLoS One. 2016;11:e0156729.
   PubMed Web of Science ®Google Scholar
• Kim EM, Jung CH, Kim J, et al. The p53/p21 complex regulates cancer cell invasion and apoptosis by targeting Bcl-2 family proteins. Cancer Res. 2017;77:3092–3100.
   PubMed Web of Science ®Google Scholar
• Rogers C, Fernandes-Alnemri T, Mayes L, et al. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat Commun. 2017;8:14128.
   PubMed Web of Science ®Google Scholar
• Alghamdi TA, Majumder S, Thieme K, et al. Janus kinase 2 regulates transcription factor EB expression and autophagy completion in glomerular podocytes. J Am Soc Nephrol. 2017;28:2641–2653.
   PubMed Web of Science ®Google Scholar
• Hamurcu Z, Delibaşı N, Geçene S, et al. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells. J Cancer Res Clin Oncol. 2018;144:415–430.
   PubMed Web of Science ®Google Scholar
• Xie H, Sun L, Lodish HF. Targeting microRNAs in obesity. Expert Opin Therap Targets. 2009;13:1227–1238.
   PubMed Web of Science ®Google Scholar
• Alisi A, Da Sacco L, Bruscalupi G, et al. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab Invest. 2011;91:283–293.
   PubMed Web of Science ®Google Scholar
• Tai A, Ohno A, Ito H. Isolation and characterization of the 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical cation-scavenging reaction products of arbutin. J Agric Food Chem. 2016;64:7285–7290.
   PubMed Web of Science ®Google Scholar
• Ertam I, Mutlu B, Unal I, et al. Efficiency of ellagic acid and arbutin in melasma: a randomized, prospective, open-label study. J Dermatol. 2008;35:570–574.
   PubMed Web of Science ®Google Scholar
• Inoue Y, Hasegawa S, Yamada T, et al. Analysis of the effects of hydroquinone and arbutin on the differentiation of melanocytes. Biol Pharm Bull. 2013;36:1722–1730.
   PubMed Web of Science ®Google Scholar
• Lim YJ, Lee EH, Kang TH, et al. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues. Arch Pharm Res. 2009;32:367–373.
   PubMed Web of Science ®Google Scholar
• Jurica K, Karačonji IB, Mikolić A, et al. In vitro safety assessment of the strawberry tree (Arbutus unedo L.) water leaf extract and arbutin in human peripheral blood lymphocytes. Cytotechnology. 2018;70:1261–1278.
   PubMed Web of Science ®Google Scholar
• Jedsadayanmata A. In vitro antiglycation activity of arbutin. NU J Sci Tech. 2013;13(2):35–41.
   Google Scholar
• Jurica K, Gobin I, Kremer D, et al. Arbutin and its metabolite hydroquinone as the main factors in the antimicrobial effect of strawberry tree (Arbutus unedo L.) leaves. J Herbal Med. 2017;8:17–23.
   Web of Science ®Google Scholar
• Zhang B, Zeng M, Li B, et al. Inhibition of oxidative stress and autophagy by arbutin in lipopolysaccharide-induced myocardial injury. Phcog Mag. 2019;15:507.
   Web of Science ®Google Scholar
• Farzanegi P, Habibian M, Anvari S. Effect of swimming training and arbutin supplement on cardiac antioxidant enzymes and oxidative stress in diabetic rats. J Gorgan University of Med Sci. 2015;17:39–44.
   Google Scholar
• Bang SH, Han SJ, Kim DH. Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity. J Cosmetic Dermatol. 2008;7:189–193.
   PubMedGoogle Scholar
• Guo XF, Yang B, Tang J, et al. Apple and pear consumption and type 2 diabetes mellitus risk: a meta-analysis of prospective cohort studies. Food Funct. 2017;8:927–934.
   PubMed Web of Science ®Google Scholar
• He F, Peng F, Xia X, et al. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia. 2014;57:1726–1736.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Peng H, Chen J, et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett. 2009;583:2009–2014.
   PubMed Web of Science ®Google Scholar
• Srivastava SP, Koya D, Kanasaki K. MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT. BioMed Res Int. 2013;2013:1.
   Web of Science ®Google Scholar
• Chen WJ, Yin K, Zhao GJ, et al. The magic and mystery of microRNA-27 in atherosclerosis. Atherosclerosis. 2012;222:314–323.
   PubMed Web of Science ®Google Scholar
• Yu K, Ji Y, Wang H, et al. Association of miR-196a2, miR-27a, and miR-499 polymorphisms with isolated congenital heart disease in a Chinese population. Genet Mol Res. 2016;15:1–14. gmr15048929.
   Google Scholar
• Karolina DS, Tavintharan S, Armugam A, et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab. 2012;97:E2271–E2276.
   PubMed Web of Science ®Google Scholar
• Wang TT, Chen YJ, Sun LL, et al. Affection of single-nucleotide polymorphisms in miR-27a, miR-124a, and miR-146a on susceptibility to type 2 diabetes mellitus in Chinese Han people. Chinese Med J. 2015;128:533–539.
   PubMed Web of Science ®Google Scholar
• Herrera BM, Lockstone HE, Taylor JM, et al. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia. 2010;53:1099–1109.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Zhong ZF, Hoi PM, Wu GS, et al. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo. J Ethnopharmacol. 2012;141:721–727.
   PubMed Web of Science ®Google Scholar
• Hamed AT, Taha MM, Nasser LM. Renoprotective effect of aliskiren monotherapy and aliskiren − pentoxifylline combination in hypertensive-diabetic type 2 patients with diabetic nephropathy. Bull Fac Pharm Cairo University. 2013;51:221–227.
   Google Scholar
• Zhang H, Li P, Burczynski FJ, et al. Attenuation of diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with a combination of Chinese herbs (Tangshen formula). Evid-Based Complementary Alternat Med. 2011;2011:1–613737.
   Web of Science ®Google Scholar
• Li GS, Jiang WL, Yue XD, et al. Effect of astilbin on experimental diabetic nephropathy in vivo and in vitro. Planta Med. 2009;75:1470–1475.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728–741.
   PubMed Web of Science ®Google Scholar
• Hartleben B, Godel M, Meyer-Schwesinger C, et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging ing mice. J Clin Invest. 2010;120:1084–1096.
   PubMed Web of Science ®Google Scholar
• Kimura T, Takabatake Y, Takahashi A, et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. JASN. 2011;22:902–913.
   Web of Science ®Google Scholar
• Chen F, Sun Z, Zhu X, et al. Astilbin inhibits high glucose-induced autophagy and apoptosis through the PI3K/Akt pathway in human proximal tubular epithelial cells. Biomed Pharmacother. 2018;106:1175–1181.
   PubMed Web of Science ®Google Scholar
• Hagiwara S, McClelland A, Kantharidis P. MicroRNA in diabetic nephropathy: renin angiotensin, aGE/RAGE, and oxidative stress pathway. J Diabetes Res. 2013;2013:1–173783.
   Web of Science ®Google Scholar
• Wu H, Kong L, Zhou S, et al. The role of microRNAs in diabetic nephropathy. J Diabetes Res. 2014;2014:920134
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao S, Wu D, et al. MicroRNA-22 promotes renal tubulointerstitial fibrosis by targeting PTEN and suppressing autophagy in diabetic nephropathy. J Diabetes Res. 2018;2018:1–4728645.
   Web of Science ®Google Scholar
• Ma Y, Yu S, Zhao W, et al. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett. 2010;298:150.
   PubMed Web of Science ®Google Scholar
• Huang S, He X, Ding J, et al. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer. 2008;123:972–978.
   PubMed Web of Science ®Google Scholar
• Guttilla IK, White BA. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem. 2009;284:23204–23216.
   PubMed Web of Science ®Google Scholar
• Hou X, Tian J, Geng J, et al. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARgamma pathway in diabetic nephropathy. Oncotarget. 2016;7:26–47760.
   Google Scholar
• Wu L, Wang Q, Guo F, et al. MicroRNA-27a induces mesangial cell injury by targeting of PPARgamma, and its in vivo knockdown prevents progression of diabetic nephropathy. Sci Rep. 2016;6:17–26072.
   PubMed Web of Science ®Google Scholar
• Xie X, Peng J, Chang X, et al. Activation of RhoA/ROCK regulates NF-kappaB signaling pathway in experimental diabetic nephropathy. Mol Cell Endocrinol. 2013;369:86–97.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu X, Zhou S, et al. SP600125 suppresses Keap1 expression and results in NRF2-mediated prevention of diabetic nephropathy. J Mol Endocrinol. 2018;60:145–157.
   PubMed Web of Science ®Google Scholar
• Lu Q, Zuo WZ, Ji XJ, et al. Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy. Phytomedicine. 2015;22:1071–1078.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Luo M, et al. Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation. Biochim Biophys Acta. 2015;1852:34–46.
   PubMed Web of Science ®Google Scholar
• Zhang L, Pang S, Deng B, et al. High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. Int J Biochem Cell Biol. 2012;44:629–638.
   PubMed Web of Science ®Google Scholar
• Gödel M, Hartleben B, Herbach N, et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest. 2011;121:2197–2209.
   PubMed Web of Science ®Google Scholar
• Mori H, Inoki K, Masutani K, et al. The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem Biophys Res Commun. 2009;384:471–475.
   PubMed Web of Science ®Google Scholar
• Yang H, Kan QE, Su Y, et al. Long non-coding RNA CASC2 improves diabetic nephropathy by inhibiting JNK pathway. Exp Clin Endocrinol Diabetes. 2018;2018. doi:10.1055/a-0629-9958
   Google Scholar
• Kuwagata S, Kume S, Chin-Kanasaki M, et al. MicroRNA148b-3p inhibits mTORC1-dependent apoptosis in diabetes by repressing TNFR2 in proximal tubular cells. Kidney Int. 2016;90:1211–1225.
   PubMed Web of Science ®Google Scholar